Literature DB >> 22552577

Irritable bowel syndrome and other gastrointestinal disorders: evaluating self-medication in an Asian community setting.

Chong-Han Kua1, Siow-Tian Ng, Reshma Lhode, Stefan Kowalski, Kok-Ann Gwee.   

Abstract

BACKGROUND: Gastrointestinal disorders frequently present symptoms which are often self-treated.
OBJECTIVE: To record demographic profile of patients visiting community pharmacies for self-treatment with medications for gastrointestinal disorders, the number of these patients who fulfilled irritable bowel syndrome diagnostic criteria, and to judge the appropriateness of their treatment requests.
SETTING: Singapore community pharmacies.
METHOD: The multicentre study was conducted using ROME III adapted criteria on adults above 18 years who have self-selected medicinal products for treatment of irritable bowel syndrome or gastrointestinal symptoms in the community pharmacy.
RESULTS: Among those seeking self-medication, 36.8 % fulfilled criteria for irritable bowel syndrome, with irritable bowel syndrome-mixed (16.3 %) being the most prevalent subtype. For patients not fulfilling criteria for irritable bowel syndrome diagnosis, rates for other functional gastrointestinal disorders were constipation (20.5 %), dyspepsia (16.3 %), gastroesophageal reflux disease (12.1 %), diarrhoea (8.9 %), bloating (4.2 %), and heartburn (3.2 %). There were more females with gastrointestinal complaints. Overall, 21.6 % of the total participants had recently sought medical attention for their gastrointestinal complaint. 20 % of patients selected inappropriate medication for their gastrointestinal complaints, and the antacids class had the highest incidence of inappropriate medication use. Possible co-existing relationships were seen between gastroesophageal reflux disease with dyspepsia, irritable bowel syndrome with gastroesophageal reflux disease, irritable bowel syndrome with dyspepsia, and diarrhoea with constipation.
CONCLUSION: Patients who fulfilled criteria for irritable bowel syndrome had a high tendency to self-treat their gastrointestinal symptoms. Constipation complaints were also common. Around one in five patients self-medicated gastrointestinal symptoms inappropriately, with antacids being the most common.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552577     DOI: 10.1007/s11096-012-9644-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  31 in total

1.  Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

Authors:  Makiko Kaji; Yasuhiro Fujiwara; Masatsugu Shiba; Yukie Kohata; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

2.  Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).

Authors:  Michel Amouretti; Claude Le Pen; Anne-Françoise Gaudin; Gilles Bommelaer; Jacques Frexinos; Philippe Ruszniewski; Thierry Poynard; Frédérique Maurel; Gaël Priol; Abdelkader El Hasnaoui
Journal:  Gastroenterol Clin Biol       Date:  2006-02

3.  Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice.

Authors:  François Guillemot; Philippe Ducrotté; Lionel Bueno
Journal:  Gastroenterol Clin Biol       Date:  2005-03

Review 4.  Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.

Authors:  Filippo Cremonini; Nicholas J Talley
Journal:  Gastroenterol Clin North Am       Date:  2005-06       Impact factor: 3.806

5.  Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.

Authors:  Shigemi Nakajima; Keiko Takahashi; Jin Sato; Masako Fukuda; Kazuo Yamamoto; Tetsuya Inoue; Yoshiaki Okumura; Yoshihide Fujiyama
Journal:  J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 4.029

6.  Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta.

Authors:  Feng Xiao Li; Scott B Patten; Robert J Hilsden; Lloyd R Sutherland
Journal:  Can J Gastroenterol       Date:  2003-04       Impact factor: 3.522

7.  The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.

Authors:  San Choon Kong; David P Hurlstone; Charlotte Y Pocock; Lucy A Walkington; Nina R Farquharson; Michael G Bramble; Mark E McAlindon; David S Sanders
Journal:  J Clin Gastroenterol       Date:  2005-02       Impact factor: 3.062

8.  Prevalence of irritable bowel syndrome in Hong Kong.

Authors:  Ambrose Chi-Pong Kwan; Wayne Hsing-Cheng Hu; Yiu-Kay Chan; Yat-Wah Yeung; Thomas Sik-To Lai; Hon Yuen
Journal:  J Gastroenterol Hepatol       Date:  2002-11       Impact factor: 4.029

9.  The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.

Authors:  Dong Won Park; Oh Young Lee; Sung Gon Shim; Dae Won Jun; Kang Nyeong Lee; Hye Young Kim; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

10.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

View more
  5 in total

1.  Symptom Comparisons Between Asian American and White American Women With Irritable Bowel Syndrome.

Authors:  Claire Jungyoun Han; Chaoqun Dong; Monica E Jarrett; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2018 May/Jun       Impact factor: 0.978

2.  Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?

Authors:  Ramin Niknam; Sarah Mousavi; Alireza Safarpour; Laleh Mahmoudi; Paria Mahmoudi
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun

Review 3.  Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review.

Authors:  Mousalreza Hosseini; Roshanak Salari; Somayeh Shariatmaghani; Batul Birjandi; Masoumeh Salari
Journal:  Electron Physician       Date:  2017-06-25

4.  Self-care use patterns in the UK, US, Australia, and Japan: a multinational web-based survey.

Authors:  Sujeong Mun; Jeong-Hwan Park; Seung-Min Baek; Minhee Lee; Sun-Mi Choi; Sanghun Lee
Journal:  Integr Med Res       Date:  2016-03-09

5.  Development and validation of the Health Promoting Behaviour for Bloating (HPB-Bloat) scale.

Authors:  Nurzulaikha Abdullah; Yee Cheng Kueh; Garry Kuan; Mung Seong Wong; Fatan Hamamah Yahaya; Nor Aslina Abd Samat; Khairil Khuzaini Zulkifli; Yeong Yeh Lee
Journal:  PeerJ       Date:  2021-06-04       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.